Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides. [electronic resource]
Producer: 20010607Description: 1061-9 p. digitalISSN:- 1019-6439
- Animals
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Camptothecin -- analogs & derivatives
- Cyclic AMP-Dependent Protein Kinases -- genetics
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Synergism
- Enzyme Inhibitors -- therapeutic use
- Female
- Humans
- Irinotecan
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Neoplasms -- drug therapy
- Nuclear Proteins
- Oligonucleotides, Antisense -- therapeutic use
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins c-mdm2
- Topoisomerase I Inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.